Revive Therapeutics Ltd
Change company Symbol lookup
Select an option...
RVVTF Revive Therapeutics Ltd
ORGN Origin Materials Inc
AHL-C Aspen Insurance Holdings Ltd
TPIC TPI Composites Inc
ALL Allstate Corp
ATEX Anterix Inc
ALKT Alkami Technology Inc
PSX Phillips 66
PSA Public Storage
PRU Prudential Financial Inc
Go

Health Care : Pharmaceuticals | Small Cap Growth
Based in Canada
Company profile

Revive Therapeutics Ltd (Revive) is engaged in commercializing treatments for rare diseases, such as Cystinuria, Wilson's disease and Rett syndrome. The Company has completed a Phase II-A study for acute gout flares in the United States. The Company's business model focuses on finding new uses of old drugs with the objective of finding a partner or partners to bring the new use drug to the marketplace. The Company is focused on the development of Bucillamine for the treatment of cystinuria (REV-004). The Company's product pipeline includes Bucillamine for the treatment of acute gout flares (REV-002), Tianeptine for treatment of Rett Syndrome (REV-003), and Bucillamine for treatment of Wilson's disease (REV-005). The Company is focused on the development and commercialization of drugs for underserved medical needs. The Company is also evaluating additional drug repurposing candidates and formulations.

Price
Delayed
$0.4096
Day's Change
0.0096 (2.40%)
Bid
--
Ask
--
B/A Size
--
Day's High
0.415
Day's Low
0.39
Volume
(Average)

Today's volume of 471,055 shares is on pace to be in-line with RVVTF's 10-day average volume of 696,417 shares.

471,055
  • Prev Close
    0.40
  • Today's Open
    0.4032
  • Day's Range
    0.39-0.415
  • Avg Vol (10-day)
    696.4K
  • Last (time)
    2:32p ET 08/05/21
  • Last (size)
    800
  • 52-Wk Range
    0.128 - 0.72
    LowHigh
  • (10/30/20 - 12/14/20)
    220.00%
  • 105.6%
  • Market Cap
    126.8M
  • Shares Outstanding
    317.1M
  • -0.06
  • --
  • No dividend
  • Ex-dividend Date
    No dividend
  • Dividend Pay Date
    No dividend
  • 0.1
  • 2.79
  • --

Earnings Calendar and Events Data provided by |Terms of Use| © 2021 Wall Street Horizon, Inc.

Market data accompanied by is delayed by at least 15 minutes for NASDAQ, NYSE MKT, NYSE, and options. Duration of the delay for other exchanges varies.
Market data and information provided by Morningstar.

Options are not suitable for all investors as the special risks inherent to options trading may expose investors to potentially rapid and substantial losses.
Please read Characteristics and Risks of Standard Options before investing in options.

"Hot" indicates urgent and noteworthy news stories as determined by providers Dow Jones or Benzinga. TD Ameritrade does not select or recommend "hot" stories.

Information and news provided by ,, , Computrade Systems, Inc., , and

Copyright © 2021. All rights reserved.